Control and monitoring of lipoprotein levels in atherosclerosis induced rabbits using novel nanoparticulate medication of Lovastatin and Rosuvastatin

Abstract Different epidemiological studies have demonstrated higher level of uric acid and Lipoprotein levels as risk factors for atherosclerosis. The present investigation deals with formulation of novel combination of Rosuvastatin and Lovastatin in nanoparticulate form to assess atherosclerosis mo...

Full description

Bibliographic Details
Main Authors: Guoyi Luo, Wenjie Chen, Jianjun Luo, Jie Liu
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Micro & Nano Letters
Online Access:https://doi.org/10.1049/mna2.12081